FDA stumbles on Flavr Savr schedule

FDA stumbles on Flavr Savr schedule

The FDA did an abrupt about-face last week, postponing its committee review of Calgene Inc.'s Flavr Savr tomato just two days after the agency published an item

Read the full 333 word article

How to gain access

Continue reading with a
two-week free trial.